HealthStream, Inc. (NASDAQ:HSTM)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $26.54 and traded as high as $28.69. HealthStream shares last traded at $28.11, with a volume of 59,406 shares.
A number of research firms have commented on HSTM. ValuEngine cut shares of HealthStream from a “buy” rating to a “hold” rating in a report on Wednesday, October 30th. BidaskClub upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a report on Thursday, November 21st. Finally, Zacks Investment Research upgraded shares of HealthStream from a “hold” rating to a “strong-buy” rating and set a $32.00 price target for the company in a report on Thursday, October 24th. Four analysts have rated the stock with a hold rating and one has issued a strong buy rating to the stock. HealthStream currently has a consensus rating of “Hold” and a consensus target price of $29.00.
The company has a debt-to-equity ratio of 0.09, a current ratio of 2.24 and a quick ratio of 2.24. The firm has a market capitalization of $926.99 million, a price-to-earnings ratio of 65.37, a PEG ratio of 5.68 and a beta of 0.64. The business’s fifty day simple moving average is $27.25 and its 200 day simple moving average is $26.54.
In other news, Director Tate Deborah Taylor sold 6,495 shares of HealthStream stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $27.96, for a total transaction of $181,600.20. Following the completion of the transaction, the director now directly owns 16,181 shares in the company, valued at $452,420.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 20.40% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of HSTM. Nuveen Asset Management LLC acquired a new position in shares of HealthStream during the second quarter valued at about $3,822,000. Mckinley Capital Management LLC Delaware purchased a new position in HealthStream during the second quarter worth about $3,059,000. Renaissance Technologies LLC boosted its holdings in HealthStream by 30.4% during the second quarter. Renaissance Technologies LLC now owns 489,900 shares of the technology company’s stock worth $12,669,000 after purchasing an additional 114,300 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in HealthStream by 84.8% during the second quarter. JPMorgan Chase & Co. now owns 247,694 shares of the technology company’s stock worth $6,449,000 after purchasing an additional 113,684 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in HealthStream by 23.8% during the second quarter. Bank of America Corp DE now owns 580,014 shares of the technology company’s stock worth $14,999,000 after purchasing an additional 111,525 shares during the last quarter. Hedge funds and other institutional investors own 72.34% of the company’s stock.
HealthStream Company Profile (NASDAQ:HSTM)
HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.
Recommended Story: How liquidity affects the bid-ask spread
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.
